Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324818 · ClinicalTrials.gov registry record · Phase 4
Treatment of Bacterial Vaginosis
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 600
- Enrollment target
NCT00324818 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 600 participants.
The verdict
NCT00324818, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 600 participants
- Enrollment target
Study Summary
We are trying to determine if longer duration of therapy with metronidazole or combination therapy of metronidazole plus azithromycin results in better cure rates for BV
Interventions
- DRUG metronidazole and azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2002-07 |
| Est. Completion | 2006-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00324818
The ClinicalTrials.gov registry entry for NCT00324818 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which metronidazole and azithromycin is the first listed.
NCT00324818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00324818 about?
NCT00324818 is a clinical study titled "Treatment of Bacterial Vaginosis". We are trying to determine if longer duration of therapy with metronidazole or combination therapy of metronidazole plus azithromycin results in better cure rates for BV
What is the current status of trial NCT00324818?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2002-07. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00324818?
The interventions under investigation include: metronidazole and azithromycin (DRUG).
Who is sponsoring clinical trial NCT00324818?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.